Zinplava, Konzentrat zur Herstellung einer Infusionslösung
7680663440011
CH-66344
Konzentrat
Associated product:
ZINPLAVA conc perf 1000 mg/40ml flac 40 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bezlotoxumabum
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
acidum penteticum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
4.57 MG | Substance | HBESI |
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 66344
- Drug name
- Zinplava, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- J06BC03
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- A
- First authorization
- 20/11/2017
- Authorization expiration date
- 30/06/2026
- IT Number
- 08.01.
- Domain
- Human medicine
Package details
- Description (FR)
- ZINPLAVA conc perf 25 mg 1 pce
- Description (DE)
- ZINPLAVA Konz Inf 25 mg 1 Stk
- Market launch
- 20/11/2017
- Market withdrawal
- 13/01/2026
- Narcotic (BTM)
- No